Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 10
Submit an article Journal homepage
174
Views
3
CrossRef citations to date
0
Altmetric
Theme: Vascular Disease - Reviews

Comparative effectiveness of revascularization strategies in stable ischemic heart disease: current perspective and literature review

Zaher FanariChristiana Care Health System, Newark, DE, USACorrespondence[email protected]
,
Sandra A WeissChristiana Care Health System, Newark, DE, USA
&
William S WeintraubChristiana Care Health System, Newark, DE, USACorrespondence[email protected]
Pages 1321-1336 | Published online: 10 Jan 2014

References

  • Favaloro RG. Vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann. Thorac. Surg. 5, 334–339 (1968).
  • Buxton BF, Komeda M, Fuller JA et al. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery. Risk-adjusted survival. Circulation 98(19 Suppl.), II1–II6 (1998).
  • Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1(8058), 263 (1978).
  • BARI-Investigators. The final 10-year follow-up results from the BARI randomized trial. J. Am. Coll. Cardiol. 49(15), 1600–1606 (2007).
  • CABRI-Invistigators. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants. Lancet 346(8984), 1179–84 (1995).
  • King SB 3rd, Kosinski AS, Guyton RA et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J. Am. Coll. Cardiol. 35(5), 1116–1121 (2000).
  • Henderson RA, Pocock SJ, Sharp SJ et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised intervention treatment of angina. Lancet 352(9138), 1419–1425 (1998).
  • Kaehler J, Koester R, Billmann W et al. 13-year follow-up of the German angioplasty bypass surgery investigation. Eur. Heart J. 26(20), 2148–2153 (2005).
  • Serruys PW, Ong AT, van Herwerden LA et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J. Am. Coll. Cardiol. 46(4), 575–581 (2005).
  • Rodriguez AE, Baldi J, Fernandez Pereira C et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J. Am. Coll. Cardiol. 46(4), 582–588 (2005).
  • Hueb W, Soares PR, Gersh BJ et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J. Am. Coll. Cardiol. 43(10), 1743–1751 (2004).
  • Booth J, Clayton T, Pepper J et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 118(4), 381–388 (2008).
  • Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 360(10), 961–972 (2009).
  • Farkouh ME, Domanski M, Sleeper LA et al. Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 367(25), 2375–2384.
  • Park SJ, Kim YH, Park DW et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N. Engl. J. Med. 364(18), 1718–1727 (2009).
  • Kamalesh M, Sharp TG, Tang XC et al. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J. Am. Coll. Cardiol. 61(8), 808–816 (2013).
  • Kapur A, Hall RJ, Malik IS et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J. Am. Coll. Cardiol. 55(5), 432–440 (2010).
  • Boudriot E, Thiele H, Walther T et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J. Am. Coll. Cardiol. 57(5), 538–545 (2010).
  • Hannan EL, Racz MJ, Walford G et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N. Engl. J. Med. 352(21), 2174–2183 (2005).
  • Hannan EL, Wu C, Walford G et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N. Engl. J. Med. 358(4), 331–341 (2008).
  • Weintraub WS, Grau-Spelveda MV, Weiss JM et al. Comparative effectiveness of revascularization strategies. N. Engl. J. Med. 366(16), 1467–1476 (2008).
  • Hlatky MA, Boothroyd DB, Baker L et al. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann. Intern. Med. 158(10), 727–734 (2013).
  • Hlatky MA, Boothroyd DB, Bravata DM et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373(9670), 1190–1197 (2009).
  • Capodanno D, Stone GW, Morice MC et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J. Am. Coll. Cardiol. 58(14), 1426–1432 (2011).
  • Head SJ, Osnabrugge RL, Kappetein AP. Long-term survival of young patients with coronary artery disease is best realized through surgical revascularization with mammary arteries. J. Am. Coll. Cardiol. 61(22), 2312–2313 (2013).
  • Stettler C, Wandel S, Allemann S et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370(9591), 937–948 (2007).
  • Daemen J, Kuck KH, Macaya C et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (arterial revascularization therapies study-Part II) trial. J. Am. Coll. Cardiol. 52(24), 1957–1967 (2008).
  • Mohr FW, Morice MC, Kappetein AP et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381(9867), 629–638 (2013).
  • Banning AP, Westaby S, Morice MC et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J. Am. Coll. Cardiol. 55(11), 1067–1075 (2013).
  • Sianos G, Morel MA, Kappetein AP et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2), 219–227 (2005).
  • Kappetein AP, Feldman TE, Mack MJ et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur. Heart J. 32(17), 2125–2134 (2005).
  • Xue ZM, Li WJ, Ma CS et al. Coronary stenting versus bypass surgery in heart failure patients with preserved ejection fraction. Chin. Med. J. (Engl.) 125(6), 1000–1004 (2005).
  • Kappetein AP, Head SJ, Morice MC et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur. J. Cardiothorac. Surg. 43(5), 1006–1013 (2013).
  • Morice MC, Serruys PW, Kappetein AP et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial. Circulation 121(24), 2645–2653 (2013).
  • Cohen DJ, Lavelle TA, Van Hout B et al. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter. Cardiovasc. Interv. 79(2), 198–209 (2013).
  • Zhang ZEF, Kolm P, Grau-Sepulveda M et al. Cost-effectiveness of revascularization strategies: a preliminary study from ASCERT. Circulation 126, A18630 (2012).
  • Magnuson EA, Farkouh ME, Fuster V et al. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes and multivessel coronary artery disease: results from the FREEDOM trial. Circulation 127(7), 820–831 (2013).
  • Hlatky MA, Rogers WJ, Johnstone I et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass angioplasty revascularization investigation (BARI) investigators. N. Engl. J. Med. 336(2), 92–99 (1997).
  • Zhang Z, Mahoney EM, Stables RH et al. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial. Circulation 108(14), 1694–1700 (2003).
  • Cohen DJ, Van Hout B, Serruys PW et al. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N. Engl. J. Med. 364(11), 1016–1026 (2003).
  • Fihn SD, Gardin JM, Abrams J et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology foundation/American heart association task force on practice guidelines, and the American college of physicians, American association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Circulation 126(25), e354–e471 (2012).
  • Holzhey DM, Jacobs S, Mochalski M et al. Minimally invasive hybrid coronary artery revascularization. Ann. Thorac. Surg. 86(6), 1856–1860 (2008).
  • Vassiliades TA Jr, Douglas JS, Morris DC et al. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome. J. Thorac. Cardiovasc. Surg. 131(5), 956–962 (2006).
  • Shen L, Hu S, Wang H et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. J. Am. Coll. Cardiol. 61(25), 2525–2533 (2013).
  • Reicher B, Poston RS, Mehra MR et al. Simultaneous “hybrid” percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am. Heart J. 155(4), 661–667 (2008).
  • Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American college of cardiology foundation appropriate use criteria task force, society for cardiovascular angiography and interventions, society of thoracic surgeons, American association for thoracic surgery, American heart association, American society of nuclear cardiology, and the society of cardiovascular computed tomography. J. Am. Coll. Cardiol. 59(9), 857–881 (2012).
  • Head SJ, Holmes DR Jr, Mack MJ et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc. Interv. 5(6), 618–625 (2012).
  • McNulty EJ, Ng W, Spertus JA et al. Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies. JACC Cardiovasc. Interv. 4(9), 1020–1027 (2011).
  • Kipp R, Lehman J, Israel J et al. Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease. Catheter. Cardiovasc. Interv. 82(2), 212–218 (2013).
  • Levine GN, Bates ER, Blankenship JC et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation 124(23), e574–e651 (2011).
  • Hillis LD, Smith PK, Anderson JL et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 124(23), 2610–2642 (2011).
  • Nashef SA, Roques F, Michel P et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur. J. Cardiothorac. Surg. 16(1), 9–13 (1999).
  • Serruys PW, Onuma Y, Garg S et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5(1), 50–56 (2009).
  • Chakravarty T, Buch MH, Naik H et al. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am. J. Cardiol. 107(3), 360–366 (2011).
  • Garg S, Sarno G, Garcia-Garcia HM et al. A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score. Circ. Cardiovasc. Interv. 3(4), 317–326 (2010).
  • Girasis C, Garg S, Raber L et al. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur. Heart J. 32(24), 3115–3127 (2011).
  • Farooq V, van Klaveren D, Steyerberg EW et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381(9867), 639–650 (2013).
  • PW S. Integrating lessons from recent clinical trials into practice: beyond the SYNTAX score. Presented at: Transcatheter Therapeutics Asia Pacific. Seoul, South Korea, 29 April 2010.
  • Soran O, Manchanda A, Schueler S. Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective. Interact. Cardiovasc. Thorac. Surg. 8(6), 666–671 (2009).
  • Head SJ, Mack MJ, Holmes DR et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur. J. Cardiothorac. Surg. 41(3), 535–541 (2012).
  • Farooq V, Serruys PW, Garcia-Garcia HM et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) trial. J. Am. Coll. Cardiol. 61(3), 282–294 (2013).
  • Shaw LJ, Berman D, Maron DJ et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117(10), 1283–1291 (2008).
  • Shaw LJ, Weintraub WS, Maron DJ et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am. Heart J. 164(2), 243–250 (2012).
  • Koo BK, Erglis A, Doh JH et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (diagnosis of ischemia-causing stenoses obtained via noninvasive fractional flow reserve) study. J. Am. Coll. Cardiol. 58(19), 1989–1997.
  • Farooq V, Brugaletta S, Serruys PW. Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention. Heart 97(23), 1902–1913 (2011).
  • Genereux P, Palmerini T, Caixeta A et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (synergy between PCI with taxus and cardiac surgery) score. J. Am. Coll. Cardiol. 59(24), 2165–2174 (2012).
  • Farooq V, Girasis C, Magro M et al. The CABG SYNTAX Score – an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy. EuroIntervention 8(11), 1277–1285.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.